TABLE 3.
Drug resistance patterns of bacteriocinogenic strains and transferabilities of bacteriocin activity with drug resistance
| Straina | Drug resistance patternb | Transfer frequencyc (% of bacteriocinogenic transconjugants)
|
|
|---|---|---|---|
| Vamr | Genr | ||
| VRE74 | Apc Gen Kan Tei Van | 2 × 10−8 (50) | <1 × 10−8 |
| VRE78 | Apc Gen Kan Tei Van | 2 × 10−6 (100) | <1 × 10−8 |
| VRE82 | Apc Gen Kan Tei Van | 2 × 10−8 (90) | <1 × 10−8 |
| VRE83 | Apc Gen Kan Tei Van | 2 × 10−7 (80) | <1 × 10−8 |
| VRE94 | Apc Gen Kan Tei Van | <1 × 10−8 | <1 × 10−8 |
| VRE252 | Apc Gen Kan Tei Van | <1 × 10−8 | 4 × 10−8 (75) |
| VRE272 | Apc Gen Kan Str Tei Van | <1 × 10−8 | 4 × 10−8 (100) |
| VRE278 | Apc Gen Kan Str Tei Van | 2 × 10−7 (75) | 4 × 10−8 (5) |
| VRE319 | Apc Gen Kan Str Tei Van | 6 × 10−8 (100) | 4 × 10−8 (35) |
| VRE330 | Apc Gen Kan Str Tei Van | <1 × 10−8 | <1 × 10−8 |
| VRE351 | Apc Gen Kan Str Tei Van | 2 × 10−7 (75) | 9 × 10−5 (8) |
| VRE367 | Apc Kan Str Tei Van | 1 × 10−7 (100) | NTd |
| VRE418 | Apc Kan Str Tei Van | <1 × 10−8 | NT |
| VRE419 | Apc Gen Kan Str Tei Van | <1 × 10−8 | <1 × 10−8 |
| VRE424 | Apc Gen Kan Str Tei Van | <1 × 10−8 | 3 × 10−8 (50) |
| VRE437 | Apc Gen Kan Str Tei Van | <1 × 10−8 | <1 × 10−8 |
| VRE455 | Apc Gen Kan Str Tei Van | <1 × 10−8 | <1 × 10−8 |
| VRE477 | Apc Gen Kan Str Tei Van | <1 × 10−8 | 2 × 10−8 (75) |
| VRE506 | Apc Kan Mino Tet Tei Van | <1 × 10−8 | NT |
| VRE576 | Apc Gen Kan Tet Tei Van | <1 × 10−8 | <1 × 10−8 |
| VRE595 | Apc Gen Kan Tet Tei Van | <1 × 10−8 | <1 × 10−8 |
a
The strains exhibited bacteriocin activity against E. faecalis, E. faecium, E. durans, L. monocytogenes, and L. denitrificans.
b
Abbreviations: Apc, ampicillin; Gen, gentamicin; Kan, kanamycin; Mino, minocycline; Str, streptomycin; Tet, tetracycline; Tei, teicoplanin; Van, vancomycin.
c
The frequency was calculated as the number of selected transconjugants per donor cell.
d
NT, not tested.